Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Polio Vaccine Schedules in Infants
NCT01633216Phase 4Completed
- Sponsor
- icddr,b
- Start
- May 2012
- Primary completion
- Dec 2012
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bivalent oral poliovirus vaccine in poliomyelitis (5 arms), sponsored by icddr,b. Primary endpoint: Antibody titers against poliovirus types 1, 2 and 3 at 7 months. Started May 2012; status: completed.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT01633216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633216.